Cat. #154758
Anti-Carcinoma associated [175F4]
Cat. #: 154758
Sub-type: Primary antibody
Unit size: 100 ug
Availability: 10-12 weeks
Target: Carcinoma-associated
Class: Monoclonal
Application: IHC
Reactivity: Human
Host: Mouse
£300.00
This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.
Contributor
Institute: Netherlands Cancer Institute
Tool Details
*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)
- Name: Anti-Carcinoma associated [175F4]
- Research fields: Cancer
- Tool sub type: Primary antibody
- Class: Monoclonal
- Conjugation: Unconjugated
- Strain: Balb/c
- Reactivity: Human
- Host: Mouse
- Application: IHC
- Description: Originally raised against the human mammary carcinoma cell line (ZR-75-1), reacts with a carcinoma-associated antigen in both adenocarcinomas and squamous cell carcinomas of different origins.
- Immunogen: Immunized with EDTA treated Human mammary carcinoma cell line (ZR-75-1)
- Isotype: IgG1
- Myeloma used: Sp2/0-Ag14
Target Details
- Target: Carcinoma-associated
- Target background: Originally raised against the human mammary carcinoma cell line (ZR-75-1), reacts with a carcinoma-associated antigen in both adenocarcinomas and squamous cell carcinomas of different origins.
Applications
- Application: IHC
Handling
- Format: Liquid
- Concentration: 0.9-1.1 mg/ml
- Unit size: 100 ug
- Storage buffer: PBS with 0.02% azide
- Storage conditions: -15° C to -25° C
- Shipping conditions: Shipping at 4° C
References
- Balm et al. 1992. Eur Arch Otorhinolaryngol. 249(5):237-42. PMID: 1524802.
